BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 195] [Article Influence: 47.8] [Reference Citation Analysis]
Number Citing Articles
1 Beyaz Coşkun A, Sağdiçoğlu Celep AG. Therapeutic modulation methods of gut microbiota and gut-liver axis. Crit Rev Food Sci Nutr 2021;:1-11. [PMID: 33749411 DOI: 10.1080/10408398.2021.1902263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maiers JL, Malhi H. Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis. Semin Liver Dis. 2019;39:235-248. [PMID: 30912096 DOI: 10.1055/s-0039-1681032] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
3 Miyata T, Nagy LE. Programmed cell death in alcohol-associated liver disease. Clin Mol Hepatol 2020;26:618-25. [PMID: 32951412 DOI: 10.3350/cmh.2020.0142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wu R, Wang X, Shao Y, Jiang Y, Zhou Y, Lu C. NFATc4 mediates ethanol-triggered hepatocyte senescence. Toxicol Lett 2021;350:10-21. [PMID: 34192554 DOI: 10.1016/j.toxlet.2021.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, Greco G, Macciò L, Meneguzzi C, Mioni D, Palmieri VO, Parisi M, Renzetti D, Rossin R, Gandin C, Bottaro LC, Bernardi M, Addolorato G, Lungaro L, Zoli G, Scafato E, Caputo F. Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA). Dig Dis Sci 2021. [PMID: 34142284 DOI: 10.1007/s10620-021-07006-1] [Reference Citation Analysis]
6 Subramaniyan V, Chakravarthi S, Jegasothy R, Seng WY, Fuloria NK, Fuloria S, Hazarika I, Das A. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicol Rep 2021;8:376-85. [PMID: 33680863 DOI: 10.1016/j.toxrep.2021.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang T, Hu L, Lu J, Xiao M, Liu J, Xia H, Lu H. Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106248] [Reference Citation Analysis]
8 Furuya S, Argemi J, Uehara T, Katou Y, Fouts DE, Schnabl B, Dubuquoy L, Belorkar A, Vadigepalli R, Kono H, Bataller R, Rusyn I. A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis. Alcohol Clin Exp Res 2020;44:87-101. [PMID: 31710124 DOI: 10.1111/acer.14234] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Shirai D, Shinkawa H, Takemura S, Tanaka S, Amano R, Kimura K, Kinoshita M, Kawada N, Kubo S. Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease. Ann Med Surg (Lond) 2021;68:102644. [PMID: 34386231 DOI: 10.1016/j.amsu.2021.102644] [Reference Citation Analysis]
10 Adhikari R, Shah R, Reyes-Gordillo K, Arellanes-Robledo J, Cheng Y, Ibrahim J, Tuma PL. Spermidine Prevents Ethanol and Lipopolysaccharide-Induced Hepatic Injury in Mice. Molecules 2021;26:1786. [PMID: 33810101 DOI: 10.3390/molecules26061786] [Reference Citation Analysis]
11 Zheng Y, Cui J, Chen AH, Zong ZM, Wei XY. Optimization of Ultrasonic-Microwave Assisted Extraction and Hepatoprotective Activities of Polysaccharides from Trametes orientalis. Molecules 2019;24:E147. [PMID: 30609723 DOI: 10.3390/molecules24010147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
12 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharmaceutica Sinica B 2021;11:3768-78. [DOI: 10.1016/j.apsb.2021.09.005] [Reference Citation Analysis]
13 Zheng TX, Pu SL, Tan P, Du YC, Qian BL, Chen H, Fu WG, Huang MZ. Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease.Front Physiol. 2020;11:595382. [PMID: 33281626 DOI: 10.3389/fphys.2020.595382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Hohmann N, Schröder F, Moreira B, Teng H, Burhenne J, Bruckner T, Mueller S, Haefeli WE, Seitz HK. Clomethiazole inhibits cytochrome P450 2E1 and improves alcoholic liver disease. Gut 2021:gutjnl-2021-324727. [PMID: 33972357 DOI: 10.1136/gutjnl-2021-324727] [Reference Citation Analysis]
15 Balbinot P, Leone S, Testino G, Caputo F. Hospital readmission of patients with hepatic encephalopathy: Is the introduction of the formal caregiver useful in care management? Dig Liver Dis 2020;52:358-9. [PMID: 31874833 DOI: 10.1016/j.dld.2019.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
16 Nguepi IST, Ngueguim FT, Gounoue RK, Mbatchou A, Dimo T. Curative effects of the aqueous extract of Tithonia diversifolia (Hemsl.) A. gray (Asteraceae) against ethanol induced-hepatotoxicity in rats. J Basic Clin Physiol Pharmacol 2021;32:1137-43. [PMID: 33561913 DOI: 10.1515/jbcpp-2019-0370] [Reference Citation Analysis]
17 Novo-Veleiro I, Herrera-Flores J, Rosón-Hernández B, Medina-García JA, Muga R, Fernández-Solá J, Martín-González MC, Seco-Hernández E, Suárez-Cuervo C, Mateos-Díaz AM, Monte-Secades R, Machado-Prieto B, Puerta-Louro R, Prada-González C, Fernández-Rial Á, Sabio-Repiso P, Vázquez-Vigo R, Antolí-Royo AC, Gomila-Grange A, Felipe-Pérez NC, Sanvisens-Bergé A, Antúnez-Jorge E, Fernández-Rodríguez CM, Alvela-Suárez L, Fidalgo-Navarro A, Castro J, Polvorosa-Gómez MA, Del Valle-Sánchez M, López-Castro J, Chamorro AJ, Marcos M; Wernicke-SEMI Group, Alcohol and Alcoholism Group, Spanish Society of Internal Medicine (SEMI). Alcoholic Liver Disease Among Patients with Wernicke Encephalopathy: A Multicenter Observational Study. Drug Alcohol Depend 2022;230:109186. [PMID: 34864357 DOI: 10.1016/j.drugalcdep.2021.109186] [Reference Citation Analysis]
18 Chen W, Zhang Q, Ding M, Yao J, Guo Y, Yan W, Yu S, Shen Q, Huang M, Zheng Y, Lin Y, Wang Y, Liu Z, Lu L. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact 2022;:109847. [PMID: 35149083 DOI: 10.1016/j.cbi.2022.109847] [Reference Citation Analysis]
19 Dong XC. PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease. Front Med (Lausanne). 2019;6:304. [PMID: 31921875 DOI: 10.3389/fmed.2019.00304] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
20 Kim HG, Huang M, Xin Y, Zhang Y, Zhang X, Wang G, Liu S, Wan J, Ahmadi AR, Sun Z, Liangpunsakul S, Xiong X, Dong XC. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice. J Hepatol 2019;71:960-9. [PMID: 31295533 DOI: 10.1016/j.jhep.2019.06.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
21 Coppens V, Morrens M, Destoop M, Dom G. The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders-A Systematic Review. Front Psychiatry 2019;10:632. [PMID: 31572234 DOI: 10.3389/fpsyt.2019.00632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Seitz HK. The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis. Chem Biol Interact 2020;316:108918. [PMID: 31836462 DOI: 10.1016/j.cbi.2019.108918] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
23 Fan M, Wang Y, Jin L, Fang Z, Peng J, Tu J, Liu Y, Zhang E, Xu S, Liu X, Huo Y, Sun Z, Chao X, Ding WX, Yan Q, Huang W. Bile Acid-Mediated Activation of Brown Fat Protects From Alcohol-Induced Steatosis and Liver Injury in Mice. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00251-4. [PMID: 34896286 DOI: 10.1016/j.jcmgh.2021.12.001] [Reference Citation Analysis]
24 Liu M, Liu M, Yang S, Shen C, Wang X, Liu W, Guo Y. Fermented milk of cheese-derived Lactobacillus bulgaricus displays potentials in alleviating alcohol-induced hepatic injury and gut dysbiosis in mice. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111283] [Reference Citation Analysis]
25 Veltkamp C, Lan S, Korompoki E, Weiss K, Schmidt H, Seitz HK. Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease. JCM 2022;11:2623. [DOI: 10.3390/jcm11092623] [Reference Citation Analysis]
26 Zhou Y, Wang S, Wan T, Huang Y, Pang N, Jiang X, Gu Y, Zhang Z, Luo J, Yang L. Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway. Free Radic Biol Med 2020;160:334-41. [PMID: 32805401 DOI: 10.1016/j.freeradbiomed.2020.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Gu CY, Lee TKW. Preclinical mouse models of hepatocellular carcinoma: An overview and update. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113042] [Reference Citation Analysis]
28 Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Asharani PV, Karuvetil MZ, Brian TYW, Satghare P, Roystonn K, Peizhi W, Cetty L, Zainuldin NA, Subramaniam M. Prevalence and Correlates of Physical Comorbidities in Alcohol Use Disorder (AUD): a Pilot Study in Treatment-Seeking Population. Int J Ment Health Addiction. [DOI: 10.1007/s11469-021-00734-5] [Reference Citation Analysis]
30 Chen J, Martin-Mateos R, Li J, Yin Z, Chen J, Lu X, Glaser KJ, Mounajjed T, Yashiro H, Siegelman J, Winkelmann CT, Wang J, Ehman RL, Shah VH, Yin M. Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease. Alcohol Clin Exp Res 2021. [PMID: 34486129 DOI: 10.1111/acer.14699] [Reference Citation Analysis]
31 Arteel GE. Liver-lung axes in alcohol-related liver disease. Clin Mol Hepatol 2020;26:670-6. [PMID: 33053938 DOI: 10.3350/cmh.2020.0174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
33 Chang Y, Ryu S, Kim Y, Cho YK, Sung E, Kim H, Ahn J, Jung H, Yun KE, Kim S, Sung K, Sohn CI, Shin H, Wild SH, Byrne CD. Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Hepatology 2020;71:861-73. [DOI: 10.1002/hep.30867] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
34 Gao B, Zhu Y, Gao N, Shen W, Stärkel P, Schnabl B. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites 2021;11:766. [PMID: 34822424 DOI: 10.3390/metabo11110766] [Reference Citation Analysis]
35 Zhao H, Liu S, Zhao H, Liu Y, Xue M, Zhang H, Qiu X, Sun Z, Liang H. Protective effects of fucoidan against ethanol-induced liver injury through maintaining mitochondrial function and mitophagy balance in rats. Food Funct 2021;12:3842-54. [PMID: 33977968 DOI: 10.1039/d0fo03220d] [Reference Citation Analysis]
36 Lee JS, Mukhopadhyay P, Matyas C, Trojnar E, Paloczi J, Yang YR, Blank BA, Savage C, Sorokin AV, Mehta NN, Vendruscolo JCM, Koob GF, Vendruscolo LF, Pacher P, Lohoff FW. PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease. Sci Rep 2019;9:17167. [PMID: 31748600 DOI: 10.1038/s41598-019-53603-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
37 Jung F, Burger K, Staltner R, Brandt A, Mueller S, Bergheim I. Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease. Nutrients 2021;13:1659. [PMID: 34068838 DOI: 10.3390/nu13051659] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
39 Qian M, Liu J, Zhao D, Cai P, Pan C, Jia W, Gao Y, Zhang Y, Zhang N, Zhang Y, Zhang Q, Wu D, Shan C, Zhang M, Schnabl B, Yang S, Shen X, Wang L. Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease. Cell Mol Gastroenterol Hepatol 2021;13:233-56. [PMID: 34454169 DOI: 10.1016/j.jcmgh.2021.08.014] [Reference Citation Analysis]
40 Sun J, Hong Z, Shao S, Li L, Yang B, Hou Y, Wang H, Xu Y, Zhang Q, Pi J, Fu J. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. Toxicol Appl Pharmacol 2021;426:115617. [PMID: 34116071 DOI: 10.1016/j.taap.2021.115617] [Reference Citation Analysis]
41 Higuera‐de‐la‐tijera F, Lira‐vera J, Morales‐gutiérrez O, Martínez‐castillo M, Medina‐ávila Z, Servín‐caamaño A, Pérez‐hernández J, Gutiérrez‐reyes G. Alcoholic Liver Disease. Clinical Liver Disease 2022;19:63-7. [DOI: 10.1002/cld.1164] [Reference Citation Analysis]
42 Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, Tsukamoto H, Kumar V. Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease. Alcohol Clin Exp Res. 2020;44:1061-1074. [PMID: 32154597 DOI: 10.1111/acer.14323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Liu J, Guan L, Zhao M, Li Q, Song A, Gao L, Lin H, Zhao J. Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study. Diabetes Metab Syndr Obes 2021;14:2829-39. [PMID: 34188506 DOI: 10.2147/DMSO.S316864] [Reference Citation Analysis]
44 Li P, Chen Y, Ke X, Zhang R, Zuo L, Wang M, Chen Z, Luo X, Wang J. Baicalin ameliorates alcohol-induced hepatic steatosis by suppressing SREBP1c elicited PNPLA3 competitive binding to ATGL. Archives of Biochemistry and Biophysics 2022;722:109236. [DOI: 10.1016/j.abb.2022.109236] [Reference Citation Analysis]
45 Li L, Bi Y, Diao S, Li X, Yuan T, Xu T, Huang C, Li J. Exosomal LncRNAs and Hepatocellular Carcinoma: From Basic Research to Clinical Practice. Biochem Pharmacol 2022;:115032. [PMID: 35395241 DOI: 10.1016/j.bcp.2022.115032] [Reference Citation Analysis]
46 Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H. Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation. Free Radic Biol Med 2021;162:571-81. [PMID: 33220424 DOI: 10.1016/j.freeradbiomed.2020.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Chembazhi UV, Bangru S, Hernaez M, Kalsotra A. Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver. Genome Res 2021;31:576-91. [PMID: 33649154 DOI: 10.1101/gr.267013.120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
48 Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] [Reference Citation Analysis]
49 Gao L, Chen X, Fu Z, Yin J, Wang Y, Sun W, Ren H, Zhang Y. Kinsenoside Alleviates Alcoholic Liver Injury by Reducing Oxidative Stress, Inhibiting Endoplasmic Reticulum Stress, and Regulating AMPK-Dependent Autophagy. Front Pharmacol 2022;12:747325. [DOI: 10.3389/fphar.2021.747325] [Reference Citation Analysis]
50 Qiu Z, Zhong D, Yang B. Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Liver Injury. In: Lin Z, Yang B, editors. Ganoderma and Health. Singapore: Springer; 2019. pp. 217-42. [DOI: 10.1007/978-981-32-9421-9_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Li L, Yang C, Li S, Liu Y, Li H, Hu S, Zhou H, Wang J, Shen H, Meng X, Li J, Xu T. TMEM88 modulates the secretion of inflammatory factors by regulating YAP signaling pathway in alcoholic liver disease. Inflamm Res 2020;69:789-800. [DOI: 10.1007/s00011-020-01360-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Silva J, Carry E, Xue C, Zhang J, Liang J, Roberge JY, Davies DL. A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice. Molecules 2021;26:1791. [PMID: 33810134 DOI: 10.3390/molecules26061791] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Ratna A, Lim A, Li Z, Argemi J, Bataller R, Chiosis G, Mandrekar P. Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease. Hepatol Commun 2021;5:1165-82. [PMID: 34278167 DOI: 10.1002/hep4.1713] [Reference Citation Analysis]
54 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
55 Hui Y, Wang X, Yu Z, Fan X, Cui B, Zhao T, Mao L, Feng H, Lin L, Yu Q, Zhang J, Wang B, Chen X, Zhao X, Sun C. Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. Pharmacological Research 2020;160:105170. [DOI: 10.1016/j.phrs.2020.105170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Sun YY, Wu DQ, Yin NN, Yang L, Chen X, Li HD, Li XF, Huang C, Meng XM, Wang H, Li J. Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver. Clin Sci (Lond) 2021;135:1213-32. [PMID: 33871024 DOI: 10.1042/CS20201363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Xiang J, Chi Y, Han J, Shi X, Cai Y, Xiang H, Xie Q. Intestinal Microbiota Contributes to the Improvement of Alcoholic Hepatitis in Mice Treated With Schisandra chinensis Extract. Front Nutr 2022;9:822429. [DOI: 10.3389/fnut.2022.822429] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhang XN, Meng FG, Wang YR, Liu SX, Zeng T. Transformed ALDH2-/- hepatocytes by ethanol could serve as a useful tool for studying alcoholic hepatocarcinogenesis. Med Hypotheses 2021;146:110366. [PMID: 33208242 DOI: 10.1016/j.mehy.2020.110366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res 2019;209:22-38. [PMID: 30853445 DOI: 10.1016/j.trsl.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
60 Zhang Y, Zheng DW, Li CX, Pan P, Zeng SM, Pan T, Zhang XZ. Temulence Therapy to Orthotopic Colorectal Tumor via Oral Administration of Fungi-Based Acetaldehyde Generator. Small Methods 2022;6:e2100951. [PMID: 35041291 DOI: 10.1002/smtd.202100951] [Reference Citation Analysis]
61 Li R, Bu Y, Yang C, Wang J. Effects of Lipid Deposition on Viscoelastic Response in Human Hepatic Cell Line HepG2. Front Physiol 2021;12:684121. [PMID: 34539426 DOI: 10.3389/fphys.2021.684121] [Reference Citation Analysis]
62 Fadriquela A, Kim CS, Lee KJ, Kang SH, Lee JH. Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease. Alcohol 2021;98:9-17. [PMID: 34695559 DOI: 10.1016/j.alcohol.2021.10.002] [Reference Citation Analysis]
63 Liu Y, Luo Y, Wang X, Luo L, Sun K, Zeng L. Gut Microbiome and Metabolome Response of Pu-erh Tea on Metabolism Disorder Induced by Chronic Alcohol Consumption. J Agric Food Chem 2020;68:6615-27. [PMID: 32419453 DOI: 10.1021/acs.jafc.0c01947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
64 Qiu L, Guo C, Hua B. Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview. Biomed Res Int 2019;2019:3808594. [PMID: 31321234 DOI: 10.1155/2019/3808594] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
65 Michalak A, Lach T, Cichoż-Lach H. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease. J Clin Med 2021;10:3011. [PMID: 34300175 DOI: 10.3390/jcm10143011] [Reference Citation Analysis]
66 Lee S, Koh H, Joo DJ, Nedumaran B, Jeon H, Park C, Harris RA, Kim YD. Induction of SIRT1 by melatonin improves alcohol‐mediated oxidative liver injury by disrupting the CRBN‐YY1‐CYP2E1 signaling pathway. J Pineal Res 2020;68. [DOI: 10.1111/jpi.12638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
67 Mueller S, Luderer M, Zhang D, Meulien D, Brach BS, Schou MB. Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis. Alcohol Alcohol 2020;55:63-70. [PMID: 31713583 DOI: 10.1093/alcalc/agz078] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ding Q, Cao F, Lai S, Zhuge H, Chang K, Valencak TG, Liu J, Li S, Ren D. Lactobacillus plantarum ZY08 relieves chronic alcohol-induced hepatic steatosis and liver injury in mice via restoring intestinal flora homeostasis. Food Research International 2022;157:111259. [DOI: 10.1016/j.foodres.2022.111259] [Reference Citation Analysis]
69 Schonfeld M, O'Neil M, Villar MT, Artigues A, Averilla J, Gunewardena S, Weinman SA, Tikhanovich I. A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice. Alcohol Clin Exp Res 2021;45:1980-93. [PMID: 34523155 DOI: 10.1111/acer.14700] [Reference Citation Analysis]
70 Queck A, Fink AF, Sirait-Fischer E, Rüschenbaum S, Thomas D, Snodgrass RG, Geisslinger G, Baba HA, Trebicka J, Zeuzem S, Weigert A, Lange CM, Brüne B. Alox12/15 Deficiency Exacerbates, While Lipoxin A4 Ameliorates Hepatic Inflammation in Murine Alcoholic Hepatitis. Front Immunol 2020;11:1447. [PMID: 32760397 DOI: 10.3389/fimmu.2020.01447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Momen-Heravi F, Catalano D, Talis A, Szabo G, Bala S. Protective effect of LNA-anti-miR-132 therapy on liver fibrosis in mice. Mol Ther Nucleic Acids 2021;25:155-67. [PMID: 34458001 DOI: 10.1016/j.omtn.2021.05.007] [Reference Citation Analysis]
72 He LH, Yao DH, Wang LY, Zhang L, Bai XL. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. Front Microbiol 2021;12:761836. [PMID: 34795655 DOI: 10.3389/fmicb.2021.761836] [Reference Citation Analysis]
73 Arumugam MK, Paal MC, Donohue TM Jr, Ganesan M, Osna NA, Kharbanda KK. Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel) 2021;10:456. [PMID: 34067313 DOI: 10.3390/biology10060456] [Reference Citation Analysis]
74 Chu J, Yan R, Wang S, Li G, Kang X, Hu Y, Lin M, Shan W, Zhao Y, Wang Z, Sun R, Yao J, Zhang N. Sinapic Acid Reduces Oxidative Stress and Pyroptosis via Inhibition of BRD4 in Alcoholic Liver Disease. Front Pharmacol 2021;12:668708. [PMID: 34149421 DOI: 10.3389/fphar.2021.668708] [Reference Citation Analysis]
75 Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019;11:E3008. [PMID: 31835303 DOI: 10.3390/nu11123008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Dolicka D, Foti M, Sobolewski C. The Emerging Role of Stress Granules in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:9428. [PMID: 34502337 DOI: 10.3390/ijms22179428] [Reference Citation Analysis]
77 Li Y, Zhang Q, Fang J, Ma N, Geng X, Xu M, Yang H, Jia X. Hepatotoxicity study of combined exposure of DEHP and ethanol: A comprehensive analysis of transcriptomics and metabolomics. Food and Chemical Toxicology 2020;141:111370. [DOI: 10.1016/j.fct.2020.111370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Fuster D, García-calvo X, Bolao F, Zuluaga P, Rocamora G, Hernández-rubio A, Sanvisens A, Tor J, Muga R. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence 2020;216:108231. [DOI: 10.1016/j.drugalcdep.2020.108231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Heinrich L, Booijink R, Khurana A, Weiskirchen R, Bansal R. Lipoxygenases in chronic liver diseases: current insights and future perspectives. Trends Pharmacol Sci 2021:S0165-6147(21)00246-7. [PMID: 34961619 DOI: 10.1016/j.tips.2021.12.001] [Reference Citation Analysis]
80 Zhang Y, Bi M, Chen Z, Dai M, Zhou G, Hu Y, Yang H, Guan W. Hydrogen gas alleviates acute alcohol-induced liver injury by inhibiting JNK activation. Exp Ther Med 2021;21:453. [PMID: 33767761 DOI: 10.3892/etm.2021.9884] [Reference Citation Analysis]
81 Winder GS, Fernandez AC, Klevering K, Mellinger JL. Confronting the Crisis of Comorbid Alcohol Use Disorder and Alcohol-Related Liver Disease With a Novel Multidisciplinary Clinic. Psychosomatics 2020;61:238-53. [PMID: 32033835 DOI: 10.1016/j.psym.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 D'Amico G, Bataller R. Need for surveillance of hepatocellular carcinoma in patients with alcoholic cirrhosis. J Hepatol 2018;69:1219-20. [PMID: 30318321 DOI: 10.1016/j.jhep.2018.09.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
83 Mao Z, Xiong J, Wang P, An J, Zhang F, Liu Z, Seung Kim J. Activity-based fluorescence probes for pathophysiological peroxynitrite fluxes. Coordination Chemistry Reviews 2022;454:214356. [DOI: 10.1016/j.ccr.2021.214356] [Reference Citation Analysis]
84 Li LX, Guo FF, Liu H, Zeng T. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets. Cell Mol Life Sci 2022;79:201. [PMID: 35325321 DOI: 10.1007/s00018-022-04239-9] [Reference Citation Analysis]
85 Foncea CG, Sporea I, Lupușoru R, Moga TV, Bende F, Șirli R, Popescu A. Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis. J Clin Med 2021;10:2338. [PMID: 34071799 DOI: 10.3390/jcm10112338] [Reference Citation Analysis]
86 Zhang Y, Kong D, Wang H. Mucosal-Associated Invariant T cell in liver diseases. Int J Biol Sci. 2020;16:460-470. [PMID: 32015682 DOI: 10.7150/ijbs.39016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
87 Monroy-Ramirez HC, Galicia-Moreno M, Sandoval-Rodriguez A, Meza-Rios A, Santos A, Armendariz-Borunda J. PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases. Int J Mol Sci 2021;22:8298. [PMID: 34361064 DOI: 10.3390/ijms22158298] [Reference Citation Analysis]
88 Wrzosek L, Ciocan D, Hugot C, Spatz M, Dupeux M, Houron C, Lievin-Le Moal V, Puchois V, Ferrere G, Trainel N, Mercier-Nomé F, Durand S, Kroemer G, Voican CS, Emond P, Straube M, Sokol H, Perlemuter G, Cassard AM. Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury. Gut 2021;70:1299-308. [PMID: 33004548 DOI: 10.1136/gutjnl-2020-321565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
89 Lin H, Chen D, Du Q, Pan T, Tu H, Xu Y, Teng T, Tu J, Li J, Lin Z, Wang X, Xu L, Chen YP. Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress. Front Physiol 2020;11:369. [PMID: 32457642 DOI: 10.3389/fphys.2020.00369] [Reference Citation Analysis]
90 Cai X, Young GM, Xie W. The xenobiotic receptors PXR and CAR in liver physiology, an update. Biochim Biophys Acta Mol Basis Dis 2021;1867:166101. [PMID: 33600998 DOI: 10.1016/j.bbadis.2021.166101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
91 Hsu MF, Koike S, Mello A, Nagy LE, Haj FG. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice. Redox Biol 2020;36:101658. [PMID: 32769011 DOI: 10.1016/j.redox.2020.101658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
92 Brol MJ, Georgiou S, Rasmussen DN, Ortiz C, Klein S, Schierwagen R, Uschner FE, Eberle L, Detlefsen S, Pantazopoulou VI, Thiele M, Filippa V, Torres S, Anastasiadou E, Krag A, Trebicka J. Effects of Ethanol Feeding in Early-Stage NAFLD Mice Induced by Western Diet. Livers 2021;1:27-39. [DOI: 10.3390/livers1010003] [Reference Citation Analysis]
93 Qiu S, Zhang A, Guan Y, Sun H, Zhang T, Han Y, Yan G, Wang X. Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease. RSC Adv 2020;10:2677-90. [DOI: 10.1039/c9ra09305b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 10.5] [Reference Citation Analysis]
94 Kim HY, Choi YJ, Kim SK, Kim H, Jun DW, Yoon K, Kim N, Hwang J, Kim YM, Lim SC, Kang KW. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome. Commun Biol 2021;4:824. [PMID: 34193972 DOI: 10.1038/s42003-021-02345-1] [Reference Citation Analysis]
95 Fujimoto Y, Kaji K, Nishimura N, Enomoto M, Murata K, Takeda S, Takaya H, Kawaratani H, Moriya K, Namisaki T, Akahane T, Yoshiji H. Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity. World J Gastroenterol 2021; 27(48): 8323-8342 [DOI: 10.3748/wjg.v27.i48.8323] [Reference Citation Analysis]
96 Bao YL, Wang L, Pan HT, Zhang TR, Chen YH, Xu SJ, Mao XL, Li SW. Animal and Organoid Models of Liver Fibrosis. Front Physiol 2021;12:666138. [PMID: 34122138 DOI: 10.3389/fphys.2021.666138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Li H, Shi J, Zhao L, Guan J, Liu F, Huo G, Li B. Lactobacillus plantarum KLDS1.0344 and Lactobacillus acidophilus KLDS1.0901 Mixture Prevents Chronic Alcoholic Liver Injury in Mice by Protecting the Intestinal Barrier and Regulating Gut Microbiota and Liver-Related Pathways. J Agric Food Chem 2021;69:183-97. [PMID: 33353302 DOI: 10.1021/acs.jafc.0c06346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
98 Mörs K, Sturm R, Hörauf JA, Kany S, Cavalli P, Omari J, Powerski M, Surov A, Marzi I, Nowak AJ, Relja B. Anti-inflammatory Effects of Alcohol Are Associated with JNK-STAT3 Downregulation in an In Vitro Inflammation Model in HepG2 Cells. Dis Markers 2021;2021:6622701. [PMID: 33791043 DOI: 10.1155/2021/6622701] [Reference Citation Analysis]
99 Jiang L, Chu H, Gao B, Lang S, Wang Y, Duan Y, Schnabl B. Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice. Dig Dis Sci 2020;65:3592-604. [PMID: 32671585 DOI: 10.1007/s10620-020-06461-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Philips CA, Augustine P, Yerol PK, Rajesh S, Mahadevan P. Severe alcoholic hepatitis: current perspectives. Hepat Med. 2019;11:97-108. [PMID: 31496843 DOI: 10.2147/hmer.s197933] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
101 Effenberger M, Widjaja AA, Grabherr F, Schaefer B, Grander C, Mayr L, Schwaerzler J, Enrich B, Moser P, Fink J, Pedrini A, Jaschke N, Kirchmair A, Pfister A, Hausmann B, Bale R, Putzer D, Zoller H, Schafer S, Pjevac P, Trajanoski Z, Oberhuber G, Adolph T, Cook S, Tilg H. Interleukin-11 drives human and mouse alcohol-related liver disease. Gut 2022:gutjnl-2021-326076. [PMID: 35365572 DOI: 10.1136/gutjnl-2021-326076] [Reference Citation Analysis]
102 Fang C, Zhou Q, Liu Q, Jia W, Xu Y. Crosstalk between gut microbiota and host lipid metabolism in a mouse model of alcoholic liver injury by chronic baijiu or ethanol feeding. Food Funct 2021. [PMID: 34927188 DOI: 10.1039/d1fo02892h] [Reference Citation Analysis]
103 Gaspers LD, Thomas AP, Hoek JB, Bartlett PJ. Ethanol Disrupts Hormone-Induced Calcium Signaling in Liver. Function (Oxf) 2021;2:zqab002. [PMID: 33604575 DOI: 10.1093/function/zqab002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Rehm J, Shield KD. Global Burden of Alcohol Use Disorders and Alcohol Liver Disease. Biomedicines 2019;7:E99. [PMID: 31847084 DOI: 10.3390/biomedicines7040099] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
105 Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology 2020;72:441-53. [PMID: 31774566 DOI: 10.1002/hep.31046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
106 Sato K, Kennedy L, Liangpunsakul S, Kusumanchi P, Yang Z, Meng F, Glaser S, Francis H, Alpini G. Intercellular Communication between Hepatic Cells in Liver Diseases. Int J Mol Sci 2019;20:E2180. [PMID: 31052525 DOI: 10.3390/ijms20092180] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
107 Lee YJ, Tsai MC, Lin HT, Wang CJ, Kao SH. Aqueous Mulberry Leaf Extract Ameliorates Alcoholic Liver Injury Associating with Upregulation of Ethanol Metabolism and Suppression of Hepatic Lipogenesis. Evid Based Complement Alternat Med 2021;2021:6658422. [PMID: 34035824 DOI: 10.1155/2021/6658422] [Reference Citation Analysis]
108 García-Ruiz C, Fernández-Checa JC. Mitochondrial Oxidative Stress and Antioxidants Balance in Fatty Liver Disease. Hepatol Commun 2018;2:1425-39. [PMID: 30556032 DOI: 10.1002/hep4.1271] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 14.0] [Reference Citation Analysis]
109 Ali Z, Saeed IM, Bybee KA, Thompson R, O'Keefe JH, Shafiq M, Saeed L, Zafar Y, Kennedy KF, Al-Sayyed L. Correlation of Hepatic Steatosis Among Cohabitants Using Hounsfield Unit From Coronary Computed Tomography. Cureus 2021;13:e17834. [PMID: 34660042 DOI: 10.7759/cureus.17834] [Reference Citation Analysis]
110 Warner J, Hardesty J, Song Y, Sun R, Deng Z, Xu R, Yin X, Zhang X, McClain C, Warner D, Kirpich I. Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration. Front Pharmacol 2021;12:711590. [PMID: 34531743 DOI: 10.3389/fphar.2021.711590] [Reference Citation Analysis]
111 Gebru YA, Choi MR, Raja G, Gupta H, Sharma SP, Choi YR, Kim HS, Yoon SJ, Kim DJ, Suk KT. Pathophysiological Roles of Mucosal-Associated Invariant T Cells in the Context of Gut Microbiota-Liver Axis. Microorganisms 2021;9:296. [PMID: 33535703 DOI: 10.3390/microorganisms9020296] [Reference Citation Analysis]
112 Luo L, Zhang J, Liu M, Qiu S, Yi S, Yu W, Liu T, Huang X, Ning F. Monofloral Triadica Cochinchinensis Honey Polyphenols Improve Alcohol-Induced Liver Disease by Regulating the Gut Microbiota of Mice. Front Immunol 2021;12:673903. [PMID: 34093575 DOI: 10.3389/fimmu.2021.673903] [Reference Citation Analysis]
113 Hong W, Mo F, Zhang Z, Huang M, Wei X. Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism. Front Cell Dev Biol 2020;8:246. [PMID: 32411700 DOI: 10.3389/fcell.2020.00246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
114 Virzì A, Roca Suarez AA, Baumert TF, Lupberger J. Oncogenic Signaling Induced by HCV Infection. Viruses 2018;10:E538. [PMID: 30279347 DOI: 10.3390/v10100538] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
115 Pohl K, Moodley P, Dhanda AD. Alcohol's Impact on the Gut and Liver. Nutrients 2021;13:3170. [PMID: 34579046 DOI: 10.3390/nu13093170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Tao Z, Zhang L, Wu T, Fang X, Zhao L. Echinacoside ameliorates alcohol-induced oxidative stress and hepatic steatosis by affecting SREBP1c/FASN pathway via PPARα. Food Chem Toxicol 2021;148:111956. [PMID: 33378712 DOI: 10.1016/j.fct.2020.111956] [Reference Citation Analysis]
117 Heck E, Gruslin K, Corder V, Petroll WM, Urban J. Positive toxicology and reactive serology in tissue donors: a retrospective study over a 3-year period. Cell Tissue Bank 2020;21:427-31. [PMID: 32246221 DOI: 10.1007/s10561-020-09827-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Gaucher J, Kinouchi K, Ceglia N, Montellier E, Peleg S, Greco CM, Schmidt A, Forne I, Masri S, Baldi P, Imhof A, Sassone-Corsi P. Distinct metabolic adaptation of liver circadian pathways to acute and chronic patterns of alcohol intake. Proc Natl Acad Sci U S A 2019;116:25250-9. [PMID: 31757851 DOI: 10.1073/pnas.1911189116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
119 Lai Y, Tan Q, Xv S, Huang S, Wang Y, Li Y, Zeng T, Mo C, Chen Y, Huang S, Zhou C, Gao L, Lv Z. Ginsenoside Rb1 Alleviates Alcohol-Induced Liver Injury by Inhibiting Steatosis, Oxidative Stress, and Inflammation. Front Pharmacol 2021;12:616409. [PMID: 33716743 DOI: 10.3389/fphar.2021.616409] [Reference Citation Analysis]
120 Zhang Y, Lu J, Zhong YJ, Yang CF, Chen L, Wu D, Song MW, Shi L, Ma ZH, Li L, Li YW. Methyl ferulic acid ameliorates alcohol-induced hepatic insulin resistance via miR-378b-mediated activation of PI3K-AKT pathway. Biomed Pharmacother 2022;145:112462. [PMID: 34844105 DOI: 10.1016/j.biopha.2021.112462] [Reference Citation Analysis]
121 Wu J, Meng QH. Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease. World J Gastroenterol 2020; 26(31): 4567-4578 [PMID: 32884217 DOI: 10.3748/wjg.v26.i31.4567] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Silva J, Spatz MH, Folk C, Chang A, Cadenas E, Liang J, Davies DL. Dihydromyricetin improves mitochondrial outcomes in the liver of alcohol-fed mice via the AMPK/Sirt-1/PGC-1α signaling axis. Alcohol 2021;91:1-9. [PMID: 33080338 DOI: 10.1016/j.alcohol.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
123 Liu XY, Chen GN, DU GM, Pan Y, Song WQ, Jiang TW, Liu HL. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice. Chin J Nat Med 2020;18:186-95. [PMID: 32245588 DOI: 10.1016/S1875-5364(20)30020-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Warner JB, Larsen IS, Hardesty JE, Song YL, Warner DR, Mcclain CJ, Sun R, Deng Z, Jensen BAH, Kirpich IA. Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice. Front Physiol 2022;12:812882. [DOI: 10.3389/fphys.2021.812882] [Reference Citation Analysis]
125 Kang H, Park Y, Lee J. Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages. Lab Invest 2021;101:1225-37. [DOI: 10.1038/s41374-021-00599-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
126 Kaufmann B, Reca A, Kim AD, Feldstein AE. Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications. Semin Liver Dis 2021;41:150-62. [PMID: 34107544 DOI: 10.1055/s-0041-1723031] [Reference Citation Analysis]
127 Mahli A, Erwin Thasler W, Hellerbrand C. Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro. Toxicol Mech Methods 2019;29:219-23. [PMID: 30380359 DOI: 10.1080/15376516.2018.1539800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
128 Hebbani AV, Vaddi DR, Dd PP, NCh V. Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes. J Ayurveda Integr Med 2021;12:330-9. [PMID: 33731264 DOI: 10.1016/j.jaim.2021.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Meng B, Zhang Y, Wang Z, Ding Q, Song J, Wang D. Hepatoprotective Effects of Morchella esculenta against Alcohol-Induced Acute Liver Injury in the C57BL/6 Mouse Related to Nrf-2 and NF-κB Signaling. Oxid Med Cell Longev 2019;2019:6029876. [PMID: 31396303 DOI: 10.1155/2019/6029876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 Yoshimura Y, Hamaguchi M, Hashimoto Y, Okamura T, Nakanishi N, Obora A, Kojima T, Fukui M. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. BMC Gastroenterol 2021;21:321. [PMID: 34372774 DOI: 10.1186/s12876-021-01893-4] [Reference Citation Analysis]
131 Huang CL, Tsai IJ, Lin WC, Lin CL, Ho IK, Wang RY, Lee CW. Reduced mortality in patients with extended duration of methadone maintenance treatment: a five-year retrospective nationwide study. Psychol Med 2021;:1-9. [PMID: 34011426 DOI: 10.1017/S0033291721002051] [Reference Citation Analysis]
132 Kuracha MR, Thomas P, Tobi M, McVicker BL. Role of cell-free network communication in alcohol-associated disorders and liver metastasis. World J Gastroenterol 2021; 27(41): 7080-7099 [PMID: 34887629 DOI: 10.3748/wjg.v27.i41.7080] [Reference Citation Analysis]
133 Wu D, Zhu H, Wang H. Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease. Front Physiol 2021;12:707429. [PMID: 34335310 DOI: 10.3389/fphys.2021.707429] [Reference Citation Analysis]
134 Sheriff L, Lalor PF. The Impact of the NLRP3 Pathway in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease. Livers 2021;1:68-81. [DOI: 10.3390/livers1020007] [Reference Citation Analysis]
135 Jadzic J, Milovanovic P, Cvetkovic D, Ivovic M, Tomanovic N, Bracanovic M, Zivkovic V, Nikolic S, Djuric M, Djonic D. Mechano-structural alteration in proximal femora of individuals with alcoholic liver disease: Implications for increased bone fragility. Bone 2021;150:116020. [PMID: 34044170 DOI: 10.1016/j.bone.2021.116020] [Reference Citation Analysis]
136 Samuvel DJ, Li L, Krishnasamy Y, Gooz M, Takemoto K, Woster PM, Lemasters JJ, Zhong Z. Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice. Autophagy 2022;:1-15. [PMID: 35293288 DOI: 10.1080/15548627.2022.2046457] [Reference Citation Analysis]
137 Wu R, Pan S, Chen Y, Nakano Y, Li M, Balog S, Tsukamoto H. Fate and functional roles of Prominin 1+ cells in liver injury and cancer. Sci Rep 2020;10:19412. [PMID: 33173221 DOI: 10.1038/s41598-020-76458-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
138 Allard J, Bucher S, Massart J, Ferron PJ, Le Guillou D, Loyant R, Daniel Y, Launay Y, Buron N, Begriche K, Borgne-Sanchez A, Fromenty B. Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol 2021;37:151-75. [PMID: 32535746 DOI: 10.1007/s10565-020-09537-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Ji M, Fang C, Jia W, Du H, Xu Y. Regulatory effect of volatile compounds in fermented alcoholic beverages on gut microbiota and serum metabolism in a mouse model. Food Funct 2021;12:5576-90. [PMID: 34008602 DOI: 10.1039/d0fo03028g] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
140 Peregud DI, Baronets VY, Lobacheva AS, Ivanov AS, Arisheva OS, Garmash IV, Kobalava ZD, Pirozhkov SV, Terebilina NN. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population. Ann Hepatol 2021;20:100247. [PMID: 32871288 DOI: 10.1016/j.aohep.2020.08.065] [Reference Citation Analysis]
141 Zhou J, Zhang N, Zhao L, Wu W, Zhang L, Zhou F, Li J. Astragalus Polysaccharides and Saponins Alleviate Liver Injury and Regulate Gut Microbiota in Alcohol Liver Disease Mice. Foods 2021;10:2688. [PMID: 34828972 DOI: 10.3390/foods10112688] [Reference Citation Analysis]
142 Thomes PG, Rasineni K, Yang L, Donohue TM Jr, Kubik JL, McNiven MA, Casey CA. Ethanol withdrawal mitigates fatty liver by normalizing lipid catabolism. Am J Physiol Gastrointest Liver Physiol. 2019;316:G509-G518. [PMID: 30714813 DOI: 10.1152/ajpgi.00376.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
143 Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc 2021:S0929-6646(21)00344-2. [PMID: 34325952 DOI: 10.1016/j.jfma.2021.07.013] [Reference Citation Analysis]
144 Li S, Song Z, Yao P, Qin J. Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy. Front Pharmacol 2022;13:848334. [DOI: 10.3389/fphar.2022.848334] [Reference Citation Analysis]
145 Warner DR, Warner JB, Hardesty JE, Song YL, Chen CY, Chen Z, Kang JX, McClain CJ, Kirpich IA. Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice. FASEB J 2021;35:e21377. [PMID: 33481293 DOI: 10.1096/fj.202001202R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Thomes PG, Rasineni K, Saraswathi V, Kharbanda KK, Clemens DL, Sweeney SA, Kubik JL, Donohue TM Jr, Casey CA. Natural Recovery by the Liver and Other Organs after Chronic Alcohol Use. Alcohol Res 2021;41:05. [PMID: 33868869 DOI: 10.35946/arcr.v41.1.05] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Zhou J, Zheng Q, Chen Z. The Nrf2 Pathway in Liver Diseases. Front Cell Dev Biol 2022;10:826204. [DOI: 10.3389/fcell.2022.826204] [Reference Citation Analysis]
148 Panday R, Monckton CP, Khetani SR. The Role of Liver Zonation in Physiology, Regeneration, and Disease. Semin Liver Dis 2022. [PMID: 35120381 DOI: 10.1055/s-0041-1742279] [Reference Citation Analysis]
149 Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. CIMB 2022;44:1294-315. [DOI: 10.3390/cimb44030087] [Reference Citation Analysis]
150 Williams JA, Ding WX. Role of autophagy in alcohol and drug-induced liver injury. Food Chem Toxicol 2020;136:111075. [PMID: 31877367 DOI: 10.1016/j.fct.2019.111075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
151 Wang C, Liu J, Yan Y, Tan Y, Jinhui L. Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research 2022;2022:1-15. [DOI: 10.1155/2022/1695802] [Reference Citation Analysis]
152 Nicoll R, Gerasimidis K, Forrest E. The Role of Micronutrients in the Pathogenesis of Alcohol-Related Liver Disease. Alcohol Alcohol 2021:agab060. [PMID: 34491307 DOI: 10.1093/alcalc/agab060] [Reference Citation Analysis]
153 Morales-Arráez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutiérrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, García-Tsao G, González JA, Verna EC, Brown RS Jr, Argemi J, Fernández-Carillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study. Am J Gastroenterol 2021. [PMID: 34962498 DOI: 10.14309/ajg.0000000000001596] [Reference Citation Analysis]
154 Xu K, Montalvo‐ortiz JL, Zhang X, Southwick SM, Krystal JH, Pietrzak RH, Gelernter J. Epigenome‐Wide DNA Methylation Association Analysis Identified Novel Loci in Peripheral Cells for Alcohol Consumption Among European American Male Veterans. Alcohol Clin Exp Res 2019;43:2111-21. [DOI: 10.1111/acer.14168] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
155 Ochiai Y, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Muraishi N, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kumada H. Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease. Hepatol Res 2021;51:62-8. [PMID: 32939922 DOI: 10.1111/hepr.13572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
156 Colquhoun SD. Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies. Liver Research 2020;4:180-90. [DOI: 10.1016/j.livres.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Han H, Desert R, Das S, Song Z, Athavale D, Ge X, Nieto N. Danger signals in liver injury and restoration of homeostasis. J Hepatol 2020;73:933-51. [PMID: 32371195 DOI: 10.1016/j.jhep.2020.04.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
158 Tête A, Gallais I, Imran M, Chevanne M, Liamin M, Sparfel L, Bucher S, Burel A, Podechard N, Appenzeller BM, Fromenty B, Grova N, Sergent O, Lagadic-gossmann D. Mechanisms involved in the death of steatotic WIF-B9 hepatocytes co-exposed to benzo[a]pyrene and ethanol: a possible key role for xenobiotic metabolism and nitric oxide. Free Radical Biology and Medicine 2018;129:323-37. [DOI: 10.1016/j.freeradbiomed.2018.09.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Kim HY, Choi YJ, Kim SK, Kim H, Jun DW, Yoon K, Kim N, Hwang J, Kim YM, Lim SC, Kang KW. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome. Commun Biol 2021;4:824. [PMID: 34193972 DOI: 10.1038/s42003-021-02345-1] [Reference Citation Analysis]
160 Choi WM, Kim HH, Kim MH, Cinar R, Yi HS, Eun HS, Kim SH, Choi YJ, Lee YS, Kim SY, Seo W, Lee JH, Shim YR, Kim YE, Yang K, Ryu T, Hwang JH, Lee CH, Choi HS, Gao B, Kim W, Kim SK, Kunos G, Jeong WI. Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis. Cell Metab 2019;30:877-889.e7. [PMID: 31474565 DOI: 10.1016/j.cmet.2019.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
161 Massart J, Begriche K, Corlu A, Fromenty B. Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. IJMS 2022;23:1062. [DOI: 10.3390/ijms23031062] [Reference Citation Analysis]
162 Yeh WJ, Tsai CC, Ko J, Yang HY. Hylocereus polyrhizus Peel Extract Retards Alcoholic Liver Disease Progression by Modulating Oxidative Stress and Inflammatory Responses in C57BL/6 Mice. Nutrients 2020;12:E3884. [PMID: 33353102 DOI: 10.3390/nu12123884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Chen C, Wang S, Yu L, Mueller J, Fortunato F, Rausch V, Mueller S. H2O2-mediated autophagy during ethanol metabolism. Redox Biol 2021;46:102081. [PMID: 34343907 DOI: 10.1016/j.redox.2021.102081] [Reference Citation Analysis]
164 Grissa D, Nytoft Rasmussen D, Krag A, Brunak S, Juhl Jensen L. Alcoholic liver disease: A registry view on comorbidities and disease prediction. PLoS Comput Biol 2020;16:e1008244. [PMID: 32960884 DOI: 10.1371/journal.pcbi.1008244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
165 Meng X, Gu Z, Xie X, Su Y, Zhang X, Ma H, Guo Y, Liu X, Cheng Y, Chang Y, Bao J. Acid sphingomyelinase mediates the noise-induced liver disorder in mice. Clin Exp Pharmacol Physiol 2019;46:556-66. [PMID: 30854677 DOI: 10.1111/1440-1681.13083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
166 Kuracha MR, Thomas P, Tobi M, McVicker BL. Role of cell-free network communication in alcohol-associated disorders and liver metastasis. World J Gastroenterol 2021; 27(41): 7080-7099 [DOI: 10.3748/wjge.v27.i41.7080] [Reference Citation Analysis]
167 Harris PS, Michel CR, Yun Y, McGinnis CD, Assiri MA, Ahmadi AR, Sun Z, Roede JR, Burchill MA, Orlicky DJ, McCullough RL, Fritz KS. Proteomic Analysis of Alcohol-associated Hepatitis Reveals Glycoprotein NMB (GPNMB) as a Novel Hepatic and Serum Biomarker. Alcohol 2021:S0741-8329(21)00148-8. [PMID: 34923085 DOI: 10.1016/j.alcohol.2021.11.005] [Reference Citation Analysis]
168 Bonnet U, Specka M, Soyka M, Alberti T, Bender S, Hilger J, Hillemacher T, Kuhlmann T, Kuhn J, Lüdecke C, Reimer J, Schneider U, Schroeder W, Stuppe M, Wiesbeck G, Wodarz N, Scherbaum N. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts]. Fortschr Neurol Psychiatr 2021. [PMID: 33634461 DOI: 10.1055/a-1363-0223] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Paganoni R, Lechel A, Vujic Spasic M. Iron at the Interface of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4097. [PMID: 33921027 DOI: 10.3390/ijms22084097] [Reference Citation Analysis]
170 Mello A, Hsu MF, Koike S, Chu B, Cheng J, Yang J, Morisseau C, Torok NJ, Hammock BD, Haj FG. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease. Cell Mol Gastroenterol Hepatol 2021;11:815-30. [PMID: 33068774 DOI: 10.1016/j.jcmgh.2020.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Li R, Mao Z, Ye X, Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms 2021;9:1017. [PMID: 34066850 DOI: 10.3390/microorganisms9051017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Wu Y, Zhang J, Yu S, Li Y, Zhu J, Zhang K, Zhang R. Cell pyroptosis in health and inflammatory diseases. Cell Death Discov 2022;8:191. [PMID: 35411030 DOI: 10.1038/s41420-022-00998-3] [Reference Citation Analysis]
173 Chen J, Argemi J, Odena G, Xu MJ, Cai Y, Massey V, Parrish A, Vadigepalli R, Altamirano J, Cabezas J, Gines P, Caballeria J, Snider N, Sancho-Bru P, Akira S, Rusyn I, Gao B, Bataller R. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension. Sci Rep 2020;10:15558. [PMID: 32968110 DOI: 10.1038/s41598-020-72172-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
174 Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 2019;70:284-93. [PMID: 30658729 DOI: 10.1016/j.jhep.2018.10.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 32.0] [Reference Citation Analysis]
175 Clemente-Sánchez A, Oliveira-Mello A, Bataller R. Moderate Alcoholic Hepatitis. Clin Liver Dis 2021;25:537-55. [PMID: 34229838 DOI: 10.1016/j.cld.2021.03.001] [Reference Citation Analysis]
176 Bataller R, Arteel GE, Moreno C, Shah V. Alcohol-related liver disease: Time for action. J Hepatol. 2019;70:221-222. [PMID: 30658723 DOI: 10.1016/j.jhep.2018.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
177 Sehrawat TS, Shah VH, Malhi H. REPLY. Hepatology 2021;73:472-3. [PMID: 32673412 DOI: 10.1002/hep.31464] [Reference Citation Analysis]
178 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
179 Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
180 Jia Q, Zhang Y, Xu B, Liao X, Bu Y, Xu Z, Duan X, Zhang Q. Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment. Aging (Albany NY) 2021;13:21216-31. [PMID: 34497155 DOI: 10.18632/aging.203424] [Reference Citation Analysis]
181 Shen S, Wang J, Lin LM. Downregulation of long non-coding RNA AIRN promotes mitophagy in alcoholic fatty hepatocytes by promoting ubiquitination of mTOR. Physiol Res 2021;70:245-53. [PMID: 33676386 DOI: 10.33549/physiolres.934549] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Anty R, Gual P. [Pathogenesis of non-alcoholic fatty liver disease]. Presse Med 2019;48:1468-83. [PMID: 31767252 DOI: 10.1016/j.lpm.2019.09.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
183 Nuciforo S, Heim MH. Organoids to model liver disease. JHEP Rep 2021;3:100198. [PMID: 33241206 DOI: 10.1016/j.jhepr.2020.100198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
184 Zhang W, Yang J, Liu J, Long X, Zhang X, Li J, Hou C. Red yeast rice prevents chronic alcohol-induced liver disease by attenuating oxidative stress and inflammatory response in mice. J Food Biochem 2021;45:e13672. [PMID: 33624852 DOI: 10.1111/jfbc.13672] [Reference Citation Analysis]
185 Ballway JW, Song BJ. Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease. Antioxidants (Basel) 2021;10:384. [PMID: 33806556 DOI: 10.3390/antiox10030384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
186 Zhong F, Guan L, Lin H, Zhao M, Qin Y, Li Q, Yuan Z, Yang G, Gao L, Zhao J. Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:760981. [PMID: 34950103 DOI: 10.3389/fendo.2021.760981] [Reference Citation Analysis]
187 Wieczorek M, Schwarz F, Sadlon A, Abderhalden LA, de Godoi Rezende Costa Molino C, Spahn DR, Schaer DJ, Orav EJ, Egli A, Bischoff-Ferrari HA; DO-HEALTH Research group. Iron deficiency and biomarkers of inflammation: a 3-year prospective analysis of the DO-HEALTH trial. Aging Clin Exp Res 2021. [PMID: 34533774 DOI: 10.1007/s40520-021-01955-3] [Reference Citation Analysis]
188 Ørntoft NW, Blé M, Baiges A, Ferrusquia J, Hernández-Gea V, Turon F, Magaz M, Møller S, Møller HJ, Garcia-Pagan JC, Gronbaek H. Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension. Front Physiol 2021;12:649668. [PMID: 34177608 DOI: 10.3389/fphys.2021.649668] [Reference Citation Analysis]
189 Ali H, Assiri MA, Shearn CT, Fritz KS. Lipid peroxidation derived reactive aldehydes in alcoholic liver disease. Curr Opin Toxicol 2019;13:110-7. [PMID: 31263795 DOI: 10.1016/j.cotox.2018.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
190 Roussey B, Calame P, Revel L, Zver T, Konan A, Piton G, Koch S, Vuitton L, Delabrousse E. Liver spontaneous hypoattenuation on CT is an imaging biomarker of the severity of acute pancreatitis. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.03.008] [Reference Citation Analysis]
191 Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol 2021; 27(23): 3223-3237 [PMID: 34163107 DOI: 10.3748/wjg.v27.i23.3223] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Baek S, Lee S, Lee Y, Kim H, Seo M, Sung S, Lee A, Kim T, Choi S, Park S, Kim T, Jeong K, Park J. Vitamin C alleviates alcoholic liver injury by suppressing neutrophil infiltration in senescence marker protein 30-knockout mice irrespective of its antioxidant effects. Life Sciences 2021. [DOI: 10.1016/j.lfs.2021.120228] [Reference Citation Analysis]
193 Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases.Cell Mol Immunol. 2021;18:4-17. [PMID: 33318628 DOI: 10.1038/s41423-020-00592-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
194 Testino G, Leone S, Balbinot P, Fagoonee S, Pellicano R. Inflammatory bowel disease and alcohol consumption. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02560-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Kim HH, Choi SE, Jeong WI. Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell. Clin Mol Hepatol 2020;26:697-704. [PMID: 33053940 DOI: 10.3350/cmh.2020.0152] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
196 Bayoumy AB, Mulder CJJ, Mol JJ, Tushuizen ME. Gut fermentation syndrome: A systematic review of case reports. United European Gastroenterol J 2021;9:332-42. [PMID: 33887125 DOI: 10.1002/ueg2.12062] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
197 Liao X, Zhan W, Li R, Tian T, Yu L, Yang Q. Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells. Biol Chem 2021;402:703-15. [PMID: 33951764 DOI: 10.1515/hsz-2020-0251] [Reference Citation Analysis]
198 Seitz HK, Neuman MG. The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology. J Clin Med 2021;10:858. [PMID: 33669694 DOI: 10.3390/jcm10040858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Winder GS, Fernandez AC, Mellinger JL. Integrated Care of Alcohol-Related Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.01.010] [Reference Citation Analysis]
200 Chernyavsky S, Dharapak P, Hui J, Laskova V, Merrill E, Pillay K, Siau E, Rizk D. Alcohol and the Hospitalized Patient. Med Clin North Am 2020;104:681-94. [PMID: 32505260 DOI: 10.1016/j.mcna.2020.02.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Schnabl B, Arteel GE, Stickel F, Hengstler J, Vartak N, Ghallab A, Dooley S, Li Y, Schwabe RF. Liver specific, systemic and genetic contributors to alcohol-related liver disease progression. Z Gastroenterol 2022;60:36-44. [PMID: 35042252 DOI: 10.1055/a-1714-9330] [Reference Citation Analysis]
202 Jiang ZB, Gao J, Chai YH, Li W, Luo YF, Chen YZ. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress. Kaohsiung J Med Sci 2021;37:718-29. [PMID: 33973356 DOI: 10.1002/kjm2.12390] [Reference Citation Analysis]
203 Pohanka M. Antidotes Against Methanol Poisoning: A Review. Mini Rev Med Chem 2019;19:1126-33. [PMID: 30864518 DOI: 10.2174/1389557519666190312150407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
204 Zou J, Wang SP, Wang YT, Wan JB. Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury. Pharmacol Res 2021;164:105388. [PMID: 33359314 DOI: 10.1016/j.phrs.2020.105388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
205 Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q. Changing Epidemiology of Hepatocellular Carcinoma in Asia. Liver Int 2022. [PMID: 35319165 DOI: 10.1111/liv.15251] [Reference Citation Analysis]
206 Zhu Y, Wang X, Zhu L, Tu Y, Chen W, Gong L, Pan T, Lin H, Lin J, Sun H, Ge Y, Wei L, Guo Y, Lu C, Chen Y, Xu L. Lactobacillus rhamnosus GG combined with inosine ameliorates alcohol-induced liver injury through regulation of intestinal barrier and Treg/Th1 cells. Toxicol Appl Pharmacol 2022;:115923. [PMID: 35176292 DOI: 10.1016/j.taap.2022.115923] [Reference Citation Analysis]
207 Park WY, Song G, Noh JH, Kim T, Kim JJ, Hong S, Park J, Um JY. Raphani Semen (Raphanus sativus L.) Ameliorates Alcoholic Fatty Liver Disease by Regulating De Novo Lipogenesis. Nutrients 2021;13:4448. [PMID: 34959999 DOI: 10.3390/nu13124448] [Reference Citation Analysis]
208 Lou Y, Wang C, Chi S, Li S, Mao Z, Liu Z. Construction of a two-photon fluorescent probe for ratiometric imaging of hypochlorous acid in alcohol-induced liver injury. Chem Commun 2019;55:12912-5. [DOI: 10.1039/c9cc06888k] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 7.7] [Reference Citation Analysis]
209 Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology 2021;73:571-85. [PMID: 32246544 DOI: 10.1002/hep.31256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
210 Chen L, Zhu Y, Hou X, Yang L, Chu H. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease. Front Med 2022;9:840752. [DOI: 10.3389/fmed.2022.840752] [Reference Citation Analysis]
211 Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross D, Lucey MR, Louvet A, Mathurin P, Garcia-Tsao G, Ho SB, Tu XM, Bataller R, Stärkel P, Fouts DE, Schnabl B. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. Hepatology 2020;71:522-38. [PMID: 31228214 DOI: 10.1002/hep.30832] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
212 Poulsen KL, Fan X, Kibler CD, Huang E, Wu X, McMullen MR, Leng L, Bucala R, Ventura-Cots M, Argemi J, Bataller R, Nagy LE. Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis. JCI Insight 2021;6:141420. [PMID: 33945507 DOI: 10.1172/jci.insight.141420] [Reference Citation Analysis]
213 Huang S, Zhou C, Zeng T, Li Y, Lai Y, Mo C, Chen Y, Huang S, Lv Z, Gao L. P-Hydroxyacetophenone Ameliorates Alcohol-Induced Steatosis and Oxidative Stress via the NF-κB Signaling Pathway in Zebrafish and Hepatocytes. Front Pharmacol 2019;10:1594. [PMID: 32047433 DOI: 10.3389/fphar.2019.01594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
214 Fromenty B. Inhibition of mitochondrial fatty acid oxidation in drug-induced hepatic steatosis. Liver Research 2019;3:157-69. [DOI: 10.1016/j.livres.2019.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
215 Jiang X, Gu Y, Huang Y, Zhou Y, Pang N, Luo J, Tang Z, Zhang Z, Yang L. CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome-Pyroptosis Pathway. Front Pharmacol 2021;12:724747. [PMID: 34630100 DOI: 10.3389/fphar.2021.724747] [Reference Citation Analysis]
216 Hao L, Zhong W, Dong H, Guo W, Sun X, Zhang W, Yue R, Li T, Griffiths A, Ahmadi AR, Sun Z, Song Z, Zhou Z. ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis. Gut 2021;70:1933-45. [PMID: 33177163 DOI: 10.1136/gutjnl-2020-321548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
217 Asiedu B, Nyakudya TT, Lembede BW, Chivandi E. Early-life exposure to alcohol and the risk of alcohol-induced liver disease in adulthood. Birth Defects Res 2021;113:451-68. [PMID: 33577143 DOI: 10.1002/bdr2.1881] [Reference Citation Analysis]
218 Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Reference Citation Analysis]
219 Wang WJ, Xiao P, Xu HQ, Niu JQ, Gao YH. Growing burden of alcoholic liver disease in China: A review. World J Gastroenterol 2019; 25(12): 1445-1456 [PMID: 30948908 DOI: 10.3748/wjg.v25.i12.1445] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
220 Cai Q, Gan C, Tang C, Wu H, Gao J. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. Front Pharmacol 2021;12:784591. [PMID: 34887768 DOI: 10.3389/fphar.2021.784591] [Reference Citation Analysis]
221 Chen H, Zhang Y, Guo T, Yang F, Mao Y, Li L, Liu C, Gao H, Jin Y, Che Y, Li Y, Huang J. Genetic variant rs72613567 of HSD17B13 gene reduces alcohol-related liver disease risk in Chinese Han population. Liver Int 2020;40:2194-202. [PMID: 33151633 DOI: 10.1111/liv.14616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
222 Trebicka J, Louvet A, Arroyo V, Jalan R, Shah VH, Moreau R. Severe alcoholic hepatitis as precipitant for organ failure and ACLF. Z Gastroenterol 2022;60:67-76. [PMID: 35042255 DOI: 10.1055/a-1713-3796] [Reference Citation Analysis]
223 Krag A, Roskams T, Pinzani M, Mueller S. Diagnostic challenges in patients with alcohol-related liver disease. Z Gastroenterol 2022;60:45-57. [PMID: 35042253 DOI: 10.1055/a-1713-4372] [Reference Citation Analysis]
224 Kim HG, Cho JH, Kim J, Kim SJ. The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. Front Physiol 2021;12:691738. [PMID: 34335299 DOI: 10.3389/fphys.2021.691738] [Reference Citation Analysis]
225 Choi RY, Ji M, Lee MK, Paik MJ. Metabolomics Study of Serum from a Chronic Alcohol-Fed Rat Model Following Administration of Defatted Tenebrio molitor Larva Fermentation Extract. Metabolites 2020;10:E436. [PMID: 33138187 DOI: 10.3390/metabo10110436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 McQuitty CE, Williams R, Chokshi S, Urbani L. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Front Immunol 2020;11:574276. [PMID: 33262757 DOI: 10.3389/fimmu.2020.574276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
227 Jadžić J, Đonić D. Compromised bone strength in patients with alcoholic liver cirrhosis. Medicinski podmladak 2020;71:27-34. [DOI: 10.5937/mp71-27443] [Reference Citation Analysis]
228 Iturrospe E, da Silva KM, Robeyns R, van de Lavoir M, Boeckmans J, Vanhaecke T, van Nuijs ALN, Covaci A. Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics. J Proteome Res 2022. [PMID: 35274962 DOI: 10.1021/acs.jproteome.2c00029] [Reference Citation Analysis]
229 Robinson K, Shah VH. Alcohol-Related Liver Disease. Clin Liver Dis (Hoboken) 2021;18:93-106. [PMID: 34745586 DOI: 10.1002/cld.1162] [Reference Citation Analysis]
230 Pan F, Cai Z, Ge H, Ma S, Yu Y, Liu J, Zhang T. Transcriptome analysis reveals the hepatoprotective mechanism of soybean meal peptides against alcohol-induced acute liver injury mice. Food Chem Toxicol 2021;154:112353. [PMID: 34146619 DOI: 10.1016/j.fct.2021.112353] [Reference Citation Analysis]
231 Gonzalez E, Azkargorta M, Garcia-Vallicrosa C, Prieto-Elordui J, Elortza F, Blanco-Sampascual S, Falcon-Perez JM. Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease? Int J Biol Sci 2021;17:1864-77. [PMID: 34131392 DOI: 10.7150/ijbs.59725] [Reference Citation Analysis]
232 Neuman MG, Mueller J, Mueller S. Non-invasive Biomarkers of Liver Inflammation and Cell Death in Response to Alcohol Detoxification. Front Physiol 2021;12:678118. [PMID: 34305638 DOI: 10.3389/fphys.2021.678118] [Reference Citation Analysis]
233 Yao S, Chen W, Zuo H, Bi Z, Zhang X, Pang L, Jing Y, Yin X, Cheng H. Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma. Biochem Genet 2021. [PMID: 34928471 DOI: 10.1007/s10528-021-10178-0] [Reference Citation Analysis]
234 Vogle A, Qian T, Zhu S, Burnett E, Fey H, Zhu Z, Keshavarzian A, Shaikh M, Hoshida Y, Kim M, Aloman C. Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumption. Sci Rep 2020;10:2451. [PMID: 32051453 DOI: 10.1038/s41598-020-59188-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [DOI: 10.1002/hep.30866] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 58.5] [Reference Citation Analysis]
236 Singhvi A, Abromitis R, Althouse AD, Bataller R, Arteel GE, Yadav D. Coexistence of alcohol-related pancreatitis and alcohol-related liver disease: A systematic review and meta-analysis. Pancreatology 2020;20:1069-77. [PMID: 32800649 DOI: 10.1016/j.pan.2020.07.412] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Teschke R. Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance. Biomedicines 2019;7:E68. [PMID: 31491888 DOI: 10.3390/biomedicines7030068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
238 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Reference Citation Analysis]
239 Rigopoulou EI, Gatselis N, Arvaniti P, Koukoulis GK, Dalekos GN. Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed. Eur J Intern Med 2021;85:86-91. [PMID: 33451888 DOI: 10.1016/j.ejim.2020.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
240 Luo P, Zheng M, Zhang R, Zhang H, Liu Y, Li W, Sun X, Yu Q, Tipoe GL, Xiao J. S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling. Acta Pharm Sin B 2021;11:668-79. [PMID: 33777674 DOI: 10.1016/j.apsb.2020.11.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
241 García-Calvo X, Bolao F, Sanvisens A, Zuluaga P, Tor J, Muga R, Fuster D. Significance of Markers of Monocyte Activation (CD163 and sCD14) and Inflammation (IL-6) in Patients Admitted for Alcohol Use Disorder Treatment. Alcohol Clin Exp Res 2020;44:152-8. [PMID: 31797394 DOI: 10.1111/acer.14228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
242 Schulze RJ, Ding WX. Lipid droplet dynamics in alcoholic fatty liver disease. Liver Res 2019;3:185-90. [PMID: 33664985 DOI: 10.1016/j.livres.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
243 Brol MJ, Rösch F, Schierwagen R, Magdaleno F, Uschner FE, Manekeller S, Queck A, Schwarzkopf K, Odenthal M, Drebber U, Thiele M, Lingohr P, Plamper A, Kristiansen G, Lotersztajn S, Krag A, Klein S, Rheinwalt KP, Trebicka J. Combination of CCl 4 with alcoholic and metabolic injuries mimics human liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;317:G182-94. [DOI: 10.1152/ajpgi.00361.2018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
244 Zhang Y, Fan Y, He W, Han Y, Bao H, Yang R, Wang B, Kong D, Wang H. Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease. Cell Biosci 2021;11:148. [PMID: 34321090 DOI: 10.1186/s13578-021-00664-8] [Reference Citation Analysis]
245 Blaya D, Rubio-Tomás T, Rodrigo-Torres D, Lozano J, Coll M, Argemi J, Altamirano J, Affò S, Morales-Ibanez O, Gratacós-Ginès J, Pose E, Tanguy M, Issoufaly T, Rautou PE, Bataller R, Caballería J, Sancho-Bru P. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis. Hepatol Int 2021;15:1006-17. [PMID: 33954832 DOI: 10.1007/s12072-021-10165-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
246 Guo W, Cao Y, You S, Wu Q, Zhang F, Han J, Lv X, Rao P, Ai L, Ni L. Ganoderic acids-rich ethanol extract from Ganoderma lucidum protects against alcoholic liver injury and modulates intestinal microbiota in mice with excessive alcohol intake. Current Research in Food Science 2022. [DOI: 10.1016/j.crfs.2022.02.013] [Reference Citation Analysis]
247 Maeda H, Ishima Y, Saruwatari J, Mizuta Y, Minayoshi Y, Ichimizu S, Yanagisawa H, Nagasaki T, Yasuda K, Oshiro S, Taura M, McConnell MJ, Oniki K, Sonoda K, Wakayama T, Kinoshita M, Shuto T, Kai H, Tanaka M, Sasaki Y, Iwakiri Y, Otagiri M, Watanabe H, Maruyama T. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. J Control Release 2021;341:457-74. [PMID: 34856227 DOI: 10.1016/j.jconrel.2021.11.039] [Reference Citation Analysis]
248 Cao S, Zhu C, Feng J, Zhu L, Yin J, Xu Y, Yang H, Huang Y, Zhang Q. Helicobacter hepaticus infection induces chronic hepatitis and fibrosis in male BALB/c mice via the activation of NF-κB, Stat3, and MAPK signaling pathways. Helicobacter 2020;25:e12677. [PMID: 31881556 DOI: 10.1111/hel.12677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
249 Gao W, Zhu Y, Ye J, Chu H. Gut non-bacterial microbiota contributing to alcohol-associated liver disease. Gut Microbes 2021;13:1984122. [PMID: 34711112 DOI: 10.1080/19490976.2021.1984122] [Reference Citation Analysis]
250 Zhou Z, Ruan B, Hu G. Anti-intoxication and protective effects of a recombinant serine protease inhibitor from Lentinula edodes against acute alcohol-induced liver injury in mice. Appl Microbiol Biotechnol 2020;104:4985-93. [PMID: 32306051 DOI: 10.1007/s00253-020-10617-9] [Reference Citation Analysis]
251 Balboa MA, de Pablo N, Meana C, Balsinde J. The role of lipins in innate immunity and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019;1864:1328-37. [DOI: 10.1016/j.bbalip.2019.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
252 Xu Q, Zhang R, Mu Y, Song Y, Hao N, Wei Y, Wang Q, Mackay CR. Propionate Ameliorates Alcohol-Induced Liver Injury in Mice via the Gut-Liver Axis: Focus on the Improvement of Intestinal Permeability. J Agric Food Chem 2022. [PMID: 35549256 DOI: 10.1021/acs.jafc.2c00633] [Reference Citation Analysis]
253 Ren X, Xin LT, Zhang MQ, Zhao Q, Yue SY, Chen KX, Guo YW, Shao CL, Wang CY. Hepatoprotective effects of a traditional Chinese medicine formula against carbon tetrachloride-induced hepatotoxicity in vivo and in vitro. Biomed Pharmacother 2019;117:109190. [PMID: 31387170 DOI: 10.1016/j.biopha.2019.109190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
254 Xiang H, Wu Z, Wang J, Wu T. Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. J Cancer 2021;12:5929-37. [PMID: 34476007 DOI: 10.7150/jca.57951] [Reference Citation Analysis]
255 Róvero Costa M, Leite Garcia J, Cristina Vágula de Almeida Silva C, Junio Togneri Ferron A, Valentini Francisqueti-Ferron F, Kurokawa Hasimoto F, Schmitt Gregolin C, Henrique Salomé de Campos D, Roberto de Andrade C, Dos Anjos Ferreira AL, Renata Corrêa C, Moreto F. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. Antioxidants (Basel) 2019;8:E276. [PMID: 31387231 DOI: 10.3390/antiox8080276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
256 Yan Y, Ren L, Liu Y, Liu L. Long non-coding RNA CRNDE as potential biomarkers facilitate inflammation and apoptosis in alcoholic liver disease. Aging (Albany NY) 2021;13:23233-44. [PMID: 34633988 DOI: 10.18632/aging.203614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Boyer-Diaz Z, Morata P, Aristu-Zabalza P, Gibert-Ramos A, Bosch J, Gracia-Sancho J. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients 2020;12:E2627. [PMID: 32872239 DOI: 10.3390/nu12092627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
258 Cai Y, Li B, Peng D, Wang X, Li P, Huang M, Xing H, Chen J. Crm1-Dependent Nuclear Export of Bach1 is Involved in the Protective Effect of Hyperoside on Oxidative Damage in Hepatocytes and CCl4-induced Acute Liver Injury. J Inflamm Res 2021;14:551-65. [PMID: 33658828 DOI: 10.2147/JIR.S279249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
259 Caiazza C, Parisi S, Caiazzo M. Liver Organoids: Updates on Disease Modeling and Biomedical Applications. Biology (Basel) 2021;10:835. [PMID: 34571712 DOI: 10.3390/biology10090835] [Reference Citation Analysis]
260 Zhou Y, Wu R, Wang X, Bao X, Lu C. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis. Cell Prolif 2022;:e13193. [PMID: 35083817 DOI: 10.1111/cpr.13193] [Reference Citation Analysis]
261 Zhang Y, Jiang M, Cui BW, Jin CH, Wu YL, Shang Y, Yang HX, Wu M, Liu J, Qiao CY, Zhan ZY, Ye H, Zheng GH, Jin Q, Lian LH, Nan JX. P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage-hepatocyte crosstalk. Br J Pharmacol 2020;177:2793-811. [PMID: 32022249 DOI: 10.1111/bph.15007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
262 Zhang G, Liu Q, Li Y, Huang C, Zhou J, Zhao Y, Wu T, Tang Q, Li R, Zhang Z, Zhang J, Huang Y, Huang H, Xia Y, Yan J, Jing X, He J. Mesencephalic astrocyte-derived neurotrophic factor alleviates alcohol induced hepatic steatosis via activating Stat3-mediated autophagy. Biochem Biophys Res Commun 2021;550:197-203. [PMID: 33713857 DOI: 10.1016/j.bbrc.2021.02.123] [Reference Citation Analysis]
263 Kong L, Chen J, Ji X, Qin Q, Yang H, Liu D, Li D, Sun M. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance. J Exp Clin Cancer Res 2021;40:18. [PMID: 33413501 DOI: 10.1186/s13046-020-01782-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
264 Yang C, He X, Zhao J, Huang W. Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease. Int Immunopharmacol 2021;92:107327. [PMID: 33412392 DOI: 10.1016/j.intimp.2020.107327] [Reference Citation Analysis]
265 Jung SJ, Hwang JH, Park EO, Lee SO, Chung YJ, Chung MJ, Lim S, Lim TJ, Ha Y, Park BH, Chae SW. Regulation of Alcohol and Acetaldehyde Metabolism by a Mixture of Lactobacillus and Bifidobacterium Species in Human. Nutrients 2021;13:1875. [PMID: 34070917 DOI: 10.3390/nu13061875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Pi A, Jiang K, Ding Q, Lai S, Yang W, Zhu J, Guo R, Fan Y, Chi L, Li S. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice. Front Pharmacol 2021;12:752148. [PMID: 34603062 DOI: 10.3389/fphar.2021.752148] [Reference Citation Analysis]
267 Rungratanawanich W, Qu Y, Wang X, Essa MM, Song BJ. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Exp Mol Med 2021;53:168-88. [PMID: 33568752 DOI: 10.1038/s12276-021-00561-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
268 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
269 Mendes BG, Schnabl B. From intestinal dysbiosis to alcohol-associated liver disease. Clin Mol Hepatol 2020;26:595-605. [PMID: 32911590 DOI: 10.3350/cmh.2020.0086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]